Literature DB >> 26867075

The Effect of Hostility Reduction on Autonomic Control of the Heart and Vasculature: A Randomized Controlled Trial.

Parisa Hajjari1, Sara Mattsson, Kathleen M McIntyre, Paula S McKinley, Peter A Shapiro, Ethan E Gorenstein, Felice A Tager, Chien-Wen J Choi, Seonjoo Lee, Richard P Sloan.   

Abstract

OBJECTIVE: Hostility is associated with coronary artery disease. One candidate mechanism may be autonomic nervous system (ANS) dysregulation. In this study, we report the effect of cognitive behavioral treatment on ANS regulation.
METHODS: Participants were 158 healthy young adults, high in hostility measured by the Cook-Medley Hostility and Spielberger Trait Anger scales. Participants were also interviewed using the Interpersonal Hostility Assessment Technique. They were randomized to a 12-week cognitive behavioral treatment program for reducing hostility or a wait-list control group. The outcome measures were preejection period, low-frequency blood pressure variability, and high-frequency heart rate variability measured at rest and in response to and recovery from cognitive and orthostatic challenge. Linear-mixed models were used to examine group by session and group by session by period interactions while controlling for sex and age. Contrasts of differential group and session effects were used to examine reactivity and recovery from challenge.
RESULTS: After Bonferroni correction, two-way and three-way interactions failed to achieve significance for preejection period, low-frequency blood pressure variability, or high-frequency heart rate variability (p > .002), indicating that hostility reduction treatment failed to influence ANS indices.
CONCLUSIONS: Reduction in anger and hostility failed to alter ANS activity at rest or in response to or recovery from challenge. These findings raise questions about whether autonomic dysregulation represents a pathophysiological link between hostility and heart disease.

Entities:  

Mesh:

Year:  2016        PMID: 26867075      PMCID: PMC5020896          DOI: 10.1097/PSY.0000000000000296

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  55 in total

1.  Spectral analysis of sympathetic discharge, R-R interval and systolic arterial pressure in decerebrate cats.

Authors:  N Montano; F Lombardi; T Gnecchi Ruscone; M Contini; M L Finocchiaro; G Baselli; A Porta; S Cerutti; A Malliani
Journal:  J Auton Nerv Syst       Date:  1992-08

2.  Reproducibility of heart rate variability and blood pressure variability in individuals with spinal cord injury.

Authors:  David S Ditor; Mark V Kamath; Maureen J Macdonald; Joanne Bugaresti; Neil McCartney; Audrey L Hicks
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

3.  Sympathetic arousal to a vestibular stressor in high and low hostile men.

Authors:  Joseph E Carmona; Alissa K Holland; Harrison J Stratton; David W Harrison
Journal:  Brain Cogn       Date:  2007-08-13       Impact factor: 2.310

4.  Left ventricular systolic time intervals as indices of postural circulatory stress in man.

Authors:  R W Stafford; W S Harris; A M Weissler
Journal:  Circulation       Date:  1970-03       Impact factor: 29.690

5.  Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis.

Authors:  C Cerutti; C Barres; C Paultre
Journal:  Am J Physiol       Date:  1994-05

6.  Comparing spectra of a series of point events particularly for heart rate variability data.

Authors:  R W DeBoer; J M Karemaker; J Strackee
Journal:  IEEE Trans Biomed Eng       Date:  1984-04       Impact factor: 4.538

7.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

8.  Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.

Authors:  Daichi Shimbo; William Chaplin; Sujith Kuruvilla; Lauren Taggart Wasson; Dennis Abraham; Matthew M Burg
Journal:  Psychosom Med       Date:  2009-07-10       Impact factor: 4.312

9.  Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-to-beat blood pressure variability.

Authors:  Raine Virtanen; Antti Jula; Jouko K Salminen; Liisa-Maria Voipio-Pulkki; Hans Helenius; Tom Kuusela; Juhani Airaksinen
Journal:  Psychosom Med       Date:  2003 Sep-Oct       Impact factor: 4.312

Review 10.  Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.

Authors:  Guido Grassi
Journal:  Hypertension       Date:  2009-08-31       Impact factor: 10.190

View more
  4 in total

1.  The Association of Cigarette Smoking With High-Frequency Heart Rate Variability: An Ecological Momentary Assessment Study.

Authors:  Fernando Bodin; Kathleen M McIntyre; Joseph E Schwartz; Paula S McKinley; Caitlyn Cardetti; Peter A Shapiro; Ethan Gorenstein; Richard P Sloan
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

2.  One-Year Cardiovascular Prognosis of the Randomized, Controlled, Short-Term Heart Rate Variability Biofeedback Among Patients with Coronary Artery Disease.

Authors:  Li-Ching Yu; I-Mei Lin; Sheng-Yu Fan; Chin-Lung Chien; Tsung-Hsien Lin
Journal:  Int J Behav Med       Date:  2018-06

Review 3.  Blood Pressure Variability and Cognitive Function: a Scoping Review.

Authors:  Nur Fazidah Asmuje; Sumaiyah Mat; Phyo Kyaw Myint; Maw Pin Tan
Journal:  Curr Hypertens Rep       Date:  2022-06-22       Impact factor: 4.592

4.  Psychological Traits, Heart Rate Variability, and Risk of Coronary Heart Disease in Healthy Aging Women-The Women's Health Initiative.

Authors:  Elena Salmoirago-Blotcher; Kathleen M Hovey; Cristopher A Andrews; Matthew Allison; Robert L Brunner; Nathalie L Denburg; Charles Eaton; Lorena Garcia; Shawnita M Sealy-Jefferson; Oleg Zaslavsky; Joseph Kang; Lenny López; Stephen G Post; Hilary Tindle; Sylvia Wassertheil-Smoller
Journal:  Psychosom Med       Date:  2019-04       Impact factor: 4.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.